More recently, in March 2024, Wegovy was This approval followed promising results from novo Nordisks SELECT trial, which followed 17,604 adults with obesity or overweight and cardiovascular disease but no history of diabetes
It is unclear whether these neural anti-inflammatory actions of GLP-1 medicines rely on GLP-1R activity
Better insulin sensitivity helps manage blood sugar levels more effectively, which can contribute to weight management
PubMed, Kadri, Selma Imamovi, et al
Research on patients using transdermal patches for neurological conditions concluded that adherence rates increased to 85.9% gradually, with patch users more likely to continue treatment than those on oral medication
Weight loss medications such as Zepbound or Wegovy may not completely leave your system for 30 days